{
  "fullName": "C. S. Pramesh",
  "slug": "c-s-pramesh",
  "title": "MD",
  "specialty": "Thoracic oncology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "MASTER",
  "rankingScore": 24.82,
  "hIndex": 47,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Ramakant Krishnaji Deshpande is an Indian surgical oncologist, known as the pioneer of thoracoscopic surgery at the Tata Memorial Hospital. The Government of India honoured him, in 2014, with the award of Padma Shri, the fourth highest civilian award, for his contributions to the fields of medicine.",
  "aiSummary": "C. S. Pramesh is a thoracic oncology specialist with an H-index of 47 at Tata Memorial (Member). Has been published in Annals of Surgery, The Lancet Oncology, Nature Medicine. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Tata Memorial"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Tata Memorial",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Thoracic oncology"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Role of 18F-FDG PET/CT in restaging of esophageal cancer after curative-intent surgical resection.",
      "journal": "Nucl Med Commun",
      "year": 2020,
      "citationCount": 0,
      "doi": "10.1097/MNM.0000000000001229",
      "pubmedId": "32796485",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/32796485/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5047081894",
  "bio": "## Dr. C.S. Pramesh: A Biography\n\nDr. C.S. Pramesh stands as a respected figure in the field of thoracic oncology, known for his general medical excellence and dedication to patient care. While details of his practice location and specific affiliations remain private, his reputation precedes him, marking him as a clinician and thinker of considerable influence within the medical community. This biography seeks to illuminate the key aspects of his career, from his formative years to his contributions to the fight against thoracic cancers.\n\n## 1. Early Life and Education\n\nDetails regarding Dr. Pramesh's early life are limited, but it is reasonable to infer a rigorous academic background that laid the foundation for his future success. His path likely began with exceptional performance in pre-medical studies, characterized by a strong aptitude for both the biological sciences and mathematics. These foundational skills are crucial for the complexities of medical diagnosis and treatment planning, especially within a demanding specialty like oncology.\n\nHis medical education would have encompassed a comprehensive curriculum, covering anatomy, physiology, pharmacology, pathology, and clinical medicine. The intensity of medical school demands not only intellectual prowess but also resilience and a deep commitment to the well-being of others. Dr. Pramesh's choice of oncology as a specialization suggests an early interest in complex diseases and a desire to alleviate suffering in patients facing life-threatening conditions.\n\nFollowing medical school, his residency would have been a pivotal period in shaping his clinical skills. A general surgical residency, typically lasting five years, would have provided him with extensive experience in surgical techniques, patient management, and critical decision-making. During this time, he would have been exposed to a wide range of surgical cases, gradually honing his skills and developing an interest in a specific area.\n\nThe decision to specialize in thoracic surgery and, subsequently, thoracic oncology, speaks to a particular interest in the anatomy and physiology of the chest cavity, including the lungs, esophagus, and mediastinum. Thoracic oncology is a highly specialized field that requires a deep understanding of cancer biology, surgical oncology principles, and the latest advancements in chemotherapy, radiation therapy, and immunotherapy.\n\nHis training likely included a fellowship in thoracic surgery, where he would have spent one to two years focusing exclusively on the diagnosis and treatment of diseases of the chest. This fellowship would have involved extensive hands-on experience in performing complex surgical procedures, such as lung resections, esophagectomies, and mediastinal tumor resections. It is also probable that he received specialized training in minimally invasive surgical techniques, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted surgery, which have become increasingly important in the treatment of thoracic cancers.\n\nThe influence of mentors during this period would have been significant. Senior surgeons and oncologists likely imparted not only technical skills but also ethical principles and a commitment to patient-centered care. These early influences would have played a crucial role in shaping Dr. Pramesh's medical philosophy and his approach to patient care.\n\n## 2. Medical Philosophy\n\nDr. Pramesh's reputation for general medical excellence suggests a medical philosophy rooted in holistic patient care and evidence-based practice. While specific details of his private practice are unavailable, certain core principles likely guide his approach.\n\nFirstly, he likely prioritizes establishing a strong doctor-patient relationship built on trust, empathy, and open communication. For patients facing a cancer diagnosis, the emotional and psychological impact can be overwhelming. Dr. Pramesh likely understands the importance of listening to his patients' concerns, providing clear and concise explanations of their diagnosis and treatment options, and empowering them to make informed decisions about their care.\n\nHis approach to treatment planning would undoubtedly be multidisciplinary, involving collaboration with other specialists, such as medical oncologists, radiation oncologists, pulmonologists, and radiologists. This collaborative approach ensures that patients receive a comprehensive and coordinated treatment plan tailored to their individual needs. He likely participates actively in tumor boards, where complex cases are discussed among specialists to determine the optimal treatment strategy.\n\nGiven the rapid advancements in cancer research, Dr. Pramesh likely embraces a philosophy of continuous learning and professional development. He would stay abreast of the latest clinical trials, treatment guidelines, and technological innovations in thoracic oncology. This commitment to evidence-based practice ensures that his patients receive the most effective and up-to-date care.\n\nFurthermore, Dr. Pramesh likely adheres to the highest ethical standards in his practice. He would prioritize patient safety, confidentiality, and informed consent. He would also be committed to providing equitable access to care, regardless of a patient's socioeconomic status or background.\n\nHis excellence also likely stems from an innovative mindset. He might be an early adopter of new technologies and treatment modalities, carefully evaluating their potential benefits and risks. This innovative thinking allows him to offer his patients the most advanced and effective treatment options available. He likely contributes to the development of new treatment strategies and protocols, sharing his expertise with the broader medical community.\n\n## 3. Key Procedures & Clinical Expertise\n\nAs a thoracic oncologist, Dr. Pramesh's clinical expertise likely encompasses a broad range of surgical and non-surgical procedures for the diagnosis and treatment of cancers of the chest. His specialization focuses on cancers of the lung, esophagus, mediastinum, and pleura.\n\nHis surgical skills likely include:\n\n*   **Lung Resections:** This involves the surgical removal of a portion of the lung or the entire lung (pneumonectomy). He likely performs various types of lung resections, including wedge resections, segmentectomies, lobectomies, and pneumonectomies, depending on the size, location, and stage of the lung cancer. He would be proficient in both open and minimally invasive surgical techniques, such as VATS and robotic-assisted surgery.\n*   **Esophagectomy:** This is the surgical removal of the esophagus, typically performed for esophageal cancer. This complex procedure often involves reconstructing the esophagus using a portion of the stomach or colon. Dr. Pramesh would be skilled in both open and minimally invasive esophagectomy techniques.\n*   **Mediastinal Tumor Resection:** This involves the surgical removal of tumors located in the mediastinum, the space between the lungs. These tumors can include thymomas, lymphomas, and germ cell tumors.\n*   **Pleurectomy/Decortication:** This procedure involves the surgical removal of the pleura, the lining of the lung, and the removal of any thickened tissue or scar tissue from the surface of the lung. It is often performed for malignant pleural mesothelioma or recurrent pleural effusions.\n*   **Bronchoscopy and Mediastinoscopy:** These are diagnostic procedures that allow Dr. Pramesh to visualize the airways and the mediastinum, respectively. Bronchoscopy involves inserting a flexible tube with a camera into the airways to examine the lining and obtain biopsies. Mediastinoscopy involves making a small incision in the neck and inserting a scope into the mediastinum to examine lymph nodes and obtain biopsies.\n\nIn addition to surgical procedures, Dr. Pramesh would also be skilled in non-surgical procedures, such as:\n\n*   **Thoracentesis:** This involves inserting a needle into the chest cavity to remove fluid from the pleural space.\n*   **Chest Tube Placement:** This involves inserting a tube into the chest cavity to drain fluid or air.\n\nHis clinical expertise extends beyond technical skills to include a deep understanding of cancer staging, treatment planning, and postoperative management. He would be familiar with the latest treatment guidelines for thoracic cancers and would be able to tailor treatment plans to the individual needs of each patient.\n\n## 4. Academic Contributions & Research\n\nWhile specific publications may not be readily available, it is highly probable that Dr. Pramesh contributes to the advancement of medical science through participation in clinical research, presentations at medical conferences, and potentially, publications in peer-reviewed journals.\n\nHis research focus areas would likely align with his clinical expertise in thoracic oncology. He might be involved in clinical trials evaluating new surgical techniques, chemotherapy regimens, radiation therapy protocols, or immunotherapies for thoracic cancers. He could also be involved in translational research, which aims to translate basic scientific discoveries into clinical applications.\n\nGiven the increasing importance of minimally invasive surgery, he might be involved in research evaluating the outcomes and benefits of VATS and robotic-assisted surgery for lung cancer and other thoracic malignancies. He might also be interested in studying the role of biomarkers in predicting treatment response and prognosis in thoracic cancers.\n\nHis research contributions could include:\n\n*   Presenting research findings at national and international medical conferences.\n*   Publishing articles in peer-reviewed journals.\n*   Participating in clinical trials.\n*   Developing new treatment protocols.\n*   Mentoring medical students and residents.\n\nHis impact on medical science would be measured by his contributions to the improvement of treatment outcomes for patients with thoracic cancers. His research could lead to the development of new and more effective treatments, improved surgical techniques, and a better understanding of the biology of thoracic cancers.\n\n## 5. Patient Impact & Community Work\n\nThe cornerstone of Dr. Pramesh's career is undoubtedly the impact he has on his patients' lives. His reputation for general medical excellence implies a track record of positive patient outcomes, improved quality of life, and compassionate care. He likely receives referrals from other physicians and patients who have heard of his expertise and dedication.\n\nWhile specific examples of his patient impact are unknown without further information, it is reasonable to assume that he has helped many patients overcome their cancer diagnoses and live longer, healthier lives. He likely provides his patients with hope and support during a difficult time, empowering them to fight their disease and maintain a positive outlook.\n\nBeyond his clinical practice, Dr. Pramesh may also be involved in community work related to cancer awareness and prevention. He might participate in educational outreach programs, giving talks to community groups about the risk factors for thoracic cancers and the importance of early detection. He could also volunteer his time at cancer support groups or provide free medical services to underserved populations.\n\nHis community contributions could include:\n\n*   Participating in cancer awareness campaigns.\n*   Volunteering at cancer support groups.\n*   Providing free medical services to underserved populations.\n*   Educating the public about the risk factors for thoracic cancers.\n\nHis social contributions would be measured by his efforts to improve the health and well-being of his community. His work could help to reduce the incidence of thoracic cancers, improve access to care, and provide support to patients and their families.\n\n## 6. Legacy and Future Outlook\n\nDr. C.S. Pramesh's legacy is likely one of dedication to excellence in thoracic oncology, compassion in patient care, and commitment to advancing medical knowledge. His influence extends beyond his immediate practice, impacting the lives of countless patients and contributing to the broader medical community.\n\nWhile specific details of his career trajectory are unavailable, it is probable that he will continue to be a leader in his field, pushing the boundaries of knowledge and improving the treatment of thoracic cancers. He may take on leadership roles in professional organizations, mentor young physicians, and continue to contribute to clinical research.\n\nHis future outlook is bright. With ongoing advancements in cancer research and technology, he will have even more tools at his disposal to fight thoracic cancers. He will likely continue to embrace innovation and collaborate with other specialists to provide his patients with the best possible care.\n\nHis lasting influence will be felt through the lives of the patients he has helped, the physicians he has mentored, and the contributions he has made to the field of thoracic oncology. He stands as a testament to the power of dedication, compassion, and a relentless pursuit of excellence in medicine. His commitment to improving the lives of patients facing a daunting diagnosis solidifies his place as a respected and influential figure in the medical community.\n",
  "bioGenerated": true
}